{"parse":{"title":"Institute for Clinical and Economic Review","pageid":50351924,"revid":849674682,"text":{"*":"<div class=\"mw-parser-output\"><p>The <b>Institute for Clinical and Economic Review</b> (ICER) is a Boston-based independent nonprofit organization that seeks to improve healthcare value by providing comprehensive clinical and cost-effectiveness analyses of treatments, tests, and procedures.<sup id=\"cite_ref-Pizzi2016_1-0\" class=\"reference\"><a href=\"#cite_note-Pizzi2016-1\">&#91;1&#93;</a></sup>\n</p><p>It was founded in about 2005 by physician-researcher <a href=\"/wiki/Steven_Pearson\" title=\"Steven Pearson\">Steven D. Pearson, MD, MSc, FRCP</a>.<sup id=\"cite_ref-Pizzi2016_1-1\" class=\"reference\"><a href=\"#cite_note-Pizzi2016-1\">&#91;1&#93;</a></sup> Until 2014 it concentrated on assessing health care costs (rather than evaluating drugs).<sup id=\"cite_ref-Silverman2016_2-0\" class=\"reference\"><a href=\"#cite_note-Silverman2016-2\">&#91;2&#93;</a></sup> It evaluates the cost effectiveness of drugs in a similar way to the <a href=\"/wiki/National_Institute_for_Health_and_Care_Excellence\" title=\"National Institute for Health and Care Excellence\">UK's NICE</a>,<sup id=\"cite_ref-Pizzi2016_1-2\" class=\"reference\"><a href=\"#cite_note-Pizzi2016-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-3\" class=\"reference\"><a href=\"#cite_note-3\">&#91;3&#93;</a></sup> and has come under some criticism from the drug industry.<sup id=\"cite_ref-Silverman2016_2-1\" class=\"reference\"><a href=\"#cite_note-Silverman2016-2\">&#91;2&#93;</a></sup> It has issued a number of drug evaluations since 2014.<sup id=\"cite_ref-Silverman2016_2-2\" class=\"reference\"><a href=\"#cite_note-Silverman2016-2\">&#91;2&#93;</a></sup> especially since July 2015.<sup id=\"cite_ref-4\" class=\"reference\"><a href=\"#cite_note-4\">&#91;4&#93;</a></sup> \nThe institution is funded by the Laura and John Arnold Foundation, drug makers, insurers, and government grants.<sup id=\"cite_ref-5\" class=\"reference\"><a href=\"#cite_note-5\">&#91;5&#93;</a></sup>\n</p>\n<div id=\"toc\" class=\"toc\"><input type=\"checkbox\" role=\"button\" id=\"toctogglecheckbox\" class=\"toctogglecheckbox\" style=\"display:none\" /><div class=\"toctitle\" lang=\"en\" dir=\"ltr\"><h2>Contents</h2><span class=\"toctogglespan\"><label class=\"toctogglelabel\" for=\"toctogglecheckbox\"></label></span></div>\n<ul>\n<li class=\"toclevel-1 tocsection-1\"><a href=\"#Threshold_cost_criteria\"><span class=\"tocnumber\">1</span> <span class=\"toctext\">Threshold cost criteria</span></a></li>\n<li class=\"toclevel-1 tocsection-2\"><a href=\"#Drugs_evaluated_-_reports_issued\"><span class=\"tocnumber\">2</span> <span class=\"toctext\">Drugs evaluated - reports issued</span></a></li>\n<li class=\"toclevel-1 tocsection-3\"><a href=\"#Drug_evaluations_planned\"><span class=\"tocnumber\">3</span> <span class=\"toctext\">Drug evaluations planned</span></a></li>\n<li class=\"toclevel-1 tocsection-4\"><a href=\"#See_also\"><span class=\"tocnumber\">4</span> <span class=\"toctext\">See also</span></a></li>\n<li class=\"toclevel-1 tocsection-5\"><a href=\"#References\"><span class=\"tocnumber\">5</span> <span class=\"toctext\">References</span></a></li>\n<li class=\"toclevel-1 tocsection-6\"><a href=\"#External_links\"><span class=\"tocnumber\">6</span> <span class=\"toctext\">External links</span></a></li>\n</ul>\n</div>\n\n<h2><span class=\"mw-headline\" id=\"Threshold_cost_criteria\">Threshold cost criteria</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Institute_for_Clinical_and_Economic_Review&amp;action=edit&amp;section=1\" title=\"Edit section: Threshold cost criteria\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>ICER estimates the amount of money available to be spent annually on new drugs and then divides that amount by the number of expected US Food and Drug Administration approvals to set an affordability benchmark.<sup id=\"cite_ref-Pizzi2016_1-3\" class=\"reference\"><a href=\"#cite_note-Pizzi2016-1\">&#91;1&#93;</a></sup>\n</p><p>ICER's affordability calculations adjust for drugs targeting prevalent diseases and/or those presenting a significant clinical benefit by setting the threshold at double the available funds divided by the expected number of new drugs (approved by FDA).<sup id=\"cite_ref-Pizzi2016_1-4\" class=\"reference\"><a href=\"#cite_note-Pizzi2016-1\">&#91;1&#93;</a></sup><sup id=\"cite_ref-Silverman2016_2-3\" class=\"reference\"><a href=\"#cite_note-Silverman2016-2\">&#91;2&#93;</a></sup>\n</p><p>After discussions in 2016 ICER broadened its quality-adjusted life year threshold to $50,000 - $150,000.<sup id=\"cite_ref-FB-PI_6-0\" class=\"reference\"><a href=\"#cite_note-FB-PI-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Drugs_evaluated_-_reports_issued\">Drugs evaluated - reports issued</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Institute_for_Clinical_and_Economic_Review&amp;action=edit&amp;section=2\" title=\"Edit section: Drugs evaluated - reports issued\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>It issued a draft report that said <a href=\"/wiki/Sovaldi\" class=\"mw-redirect\" title=\"Sovaldi\">Sovaldi</a> wasn\u2019t worth the list price of about $84,000 a year.<sup id=\"cite_ref-Silverman2016_2-4\" class=\"reference\"><a href=\"#cite_note-Silverman2016-2\">&#91;2&#93;</a></sup>\n</p><p>As of May 2016 ICER published final reports on\n</p><p>- Multiple myeloma\n- Palliative care<sup id=\"cite_ref-7\" class=\"reference\"><a href=\"#cite_note-7\">&#91;7&#93;</a></sup>\n</p>\n<table class=\"plainlinks metadata ambox mbox-small-left ambox-content\" role=\"presentation\"><tbody><tr><td class=\"mbox-image\"><a href=\"/wiki/File:Wiki_letter_w_cropped.svg\" class=\"image\"><img alt=\"[icon]\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/20px-Wiki_letter_w_cropped.svg.png\" width=\"20\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/30px-Wiki_letter_w_cropped.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/1/1c/Wiki_letter_w_cropped.svg/40px-Wiki_letter_w_cropped.svg.png 2x\" data-file-width=\"44\" data-file-height=\"31\" /></a></td><td class=\"mbox-text\"><div class=\"mbox-text-span\">This section <b>needs expansion</b>. <small>You can help by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Institute_for_Clinical_and_Economic_Review&amp;action=edit&amp;section=\">adding to it</a>.</small>  <small><i>(April 2016)</i></small></div></td></tr></tbody></table> \n<p>It has criticised the high price of drugs for osteoporosis, multiple sclerosis, PCSK9 cholesterol meds, and immuno-oncology therapies.<sup id=\"cite_ref-FB-PI_6-1\" class=\"reference\"><a href=\"#cite_note-FB-PI-6\">&#91;6&#93;</a></sup><sup id=\"cite_ref-8\" class=\"reference\"><a href=\"#cite_note-8\">&#91;8&#93;</a></sup>\n</p><p>In 2017 it issued a controversial draft report on <a href=\"/wiki/PARP_inhibitor\" title=\"PARP inhibitor\">PARP inhibitors</a> for ovarian cancer.<sup id=\"cite_ref-FB-PI_6-2\" class=\"reference\"><a href=\"#cite_note-FB-PI-6\">&#91;6&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"Drug_evaluations_planned\">Drug evaluations planned</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Institute_for_Clinical_and_Economic_Review&amp;action=edit&amp;section=3\" title=\"Edit section: Drug evaluations planned\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<p>A preliminary list of drugs to be evaluated includes <a href=\"/wiki/Rociletinib\" title=\"Rociletinib\">rociletinib</a>, <a href=\"/wiki/AZD-9291\" class=\"mw-redirect\" title=\"AZD-9291\">AZD-9291</a>, <a href=\"/wiki/Necitumumab\" title=\"Necitumumab\">necitumumab</a>, <a href=\"/wiki/Nivolumab\" title=\"Nivolumab\">nivolumab</a>, and <a href=\"/wiki/Pembrolizumab\" title=\"Pembrolizumab\">pembrolizumab</a> for small-cell lung cancer; <a href=\"/wiki/Fingolimod\" title=\"Fingolimod\">fingolimod</a>, <a href=\"/wiki/Dimethyl_fumarate\" title=\"Dimethyl fumarate\">dimethyl fumarate</a>, <a href=\"/wiki/Teriflunomide\" title=\"Teriflunomide\">teriflunomide</a>, <a href=\"/wiki/Alemtuzumab\" title=\"Alemtuzumab\">alemtuzumab</a>, and <a href=\"/wiki/Daclizumab\" title=\"Daclizumab\">daclizumab</a> for multiple sclerosis; and <a href=\"/wiki/Ixekizumab\" title=\"Ixekizumab\">ixekizumab</a> and <a href=\"/wiki/Brodalumab\" title=\"Brodalumab\">brodalumab</a> for psoriasis or <a href=\"/wiki/Psoriatic_arthritis\" title=\"Psoriatic arthritis\">psoriatic arthritis</a>.<sup id=\"cite_ref-Pizzi2016_1-5\" class=\"reference\"><a href=\"#cite_note-Pizzi2016-1\">&#91;1&#93;</a></sup>\n</p>\n<h2><span class=\"mw-headline\" id=\"See_also\">See also</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Institute_for_Clinical_and_Economic_Review&amp;action=edit&amp;section=4\" title=\"Edit section: See also\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a href=\"/wiki/Academy_of_Managed_Care_Pharmacy\" title=\"Academy of Managed Care Pharmacy\">Academy of Managed Care Pharmacy</a>, an older US organisation that evaluates drug cost effectiveness</li></ul>\n<h2><span class=\"mw-headline\" id=\"References\">References</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Institute_for_Clinical_and_Economic_Review&amp;action=edit&amp;section=5\" title=\"Edit section: References\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<div class=\"reflist\" style=\"list-style-type: decimal;\">\n<div class=\"mw-references-wrap\"><ol class=\"references\">\n<li id=\"cite_note-Pizzi2016-1\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Pizzi2016_1-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Pizzi2016_1-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Pizzi2016_1-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Pizzi2016_1-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Pizzi2016_1-4\"><sup><i><b>e</b></i></sup></a> <a href=\"#cite_ref-Pizzi2016_1-5\"><sup><i><b>f</b></i></sup></a></span> <span class=\"reference-text\"><cite class=\"citation journal\">Pizzi, LT. <a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4822973\">\"The Institute for Clinical and Economic Review and Its Growing Influence on the US Healthcare\"</a>. <i>Am Health Drug Benefits</i>. <b>9</b>: 9\u201310. <a href=\"/wiki/PubMed_Central\" title=\"PubMed Central\">PMC</a>&#160;<span class=\"plainlinks\"><a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pmc/articles/PMC4822973\">4822973</a>&#8239;<img alt=\"Freely accessible\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png\" title=\"Freely accessible\" width=\"9\" height=\"14\" srcset=\"//upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/14px-Lock-green.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/18px-Lock-green.svg.png 2x\" data-file-width=\"512\" data-file-height=\"813\" /></span>. <a href=\"/wiki/PubMed_Identifier\" class=\"mw-redirect\" title=\"PubMed Identifier\">PMID</a>&#160;<a rel=\"nofollow\" class=\"external text\" href=\"//www.ncbi.nlm.nih.gov/pubmed/27066190\">27066190</a>.</cite><span title=\"ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.genre=article&amp;rft.jtitle=Am+Health+Drug+Benefits&amp;rft.atitle=The+Institute+for+Clinical+and+Economic+Review+and+Its+Growing+Influence+on+the+US+Healthcare&amp;rft.volume=9&amp;rft.pages=9-10&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4822973&amp;rft_id=info%3Apmid%2F27066190&amp;rft.aulast=Pizzi&amp;rft.aufirst=LT&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC4822973&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AInstitute+for+Clinical+and+Economic+Review\" class=\"Z3988\"><span style=\"display:none;\">&#160;</span></span></span>\n</li>\n<li id=\"cite_note-Silverman2016-2\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-Silverman2016_2-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-Silverman2016_2-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-Silverman2016_2-2\"><sup><i><b>c</b></i></sup></a> <a href=\"#cite_ref-Silverman2016_2-3\"><sup><i><b>d</b></i></sup></a> <a href=\"#cite_ref-Silverman2016_2-4\"><sup><i><b>e</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"https://www.statnews.com/pharmalot/2016/04/12/drug-prices-icer/\">This nonprofit is playing a valuable role in framing the drug price discussion. Silverman. April 2016</a></span>\n</li>\n<li id=\"cite_note-3\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-3\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.ajpb.com/articles/institute-for-clinical-and-economic-review-seeks-to-enhance-healthcare-value\">Institute for Clinical and Economic Review Seeks to Enhance Healthcare Value.</a></span>\n</li>\n<li id=\"cite_note-4\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-4\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.modernhealthcare.com/article/20150721/NEWS/150729948\">Series of reports will analyze cost, benefit of pricey drugs</a></span>\n</li>\n<li id=\"cite_note-5\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-5\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"https://www.statnews.com/pharmalot/2016/04/12/drug-prices-icer/\">https://www.statnews.com/pharmalot/2016/04/12/drug-prices-icer/</a></span>\n</li>\n<li id=\"cite_note-FB-PI-6\"><span class=\"mw-cite-backlink\">^ <a href=\"#cite_ref-FB-PI_6-0\"><sup><i><b>a</b></i></sup></a> <a href=\"#cite_ref-FB-PI_6-1\"><sup><i><b>b</b></i></sup></a> <a href=\"#cite_ref-FB-PI_6-2\"><sup><i><b>c</b></i></sup></a></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fiercepharma.com/pharma/parp-drugs-from-az-clovis-and-tesaro-are-largely-overpriced-watchdog-says\">Cancer-fighting PARP drugs from AstraZeneca, Clovis and Tesaro largely overpriced, watchdog says. July 2017</a></span>\n</li>\n<li id=\"cite_note-7\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-7\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external free\" href=\"http://icer-review.org/materials/\">http://icer-review.org/materials/</a></span>\n</li>\n<li id=\"cite_note-8\"><span class=\"mw-cite-backlink\"><b><a href=\"#cite_ref-8\">^</a></b></span> <span class=\"reference-text\"><a rel=\"nofollow\" class=\"external text\" href=\"http://www.fiercepharma.com/pharma/are-new-bone-drugs-from-amgen-and-radius-cost-effective-not-even-close-icer-says\">Are new bone drugs from Amgen and Radius cost-effective? Not even close, ICER says. May 2017</a></span>\n</li>\n</ol></div></div>\n<h2><span class=\"mw-headline\" id=\"External_links\">External links</span><span class=\"mw-editsection\"><span class=\"mw-editsection-bracket\">[</span><a href=\"/w/index.php?title=Institute_for_Clinical_and_Economic_Review&amp;action=edit&amp;section=6\" title=\"Edit section: External links\">edit</a><span class=\"mw-editsection-bracket\">]</span></span></h2>\n<ul><li><a rel=\"nofollow\" class=\"external text\" href=\"https://icer-review.org/\">ICER website</a></li></ul>\n<p><br />\n</p>\n<table class=\"metadata plainlinks stub\" role=\"presentation\" style=\"background:transparent\"><tbody><tr><td><a href=\"/wiki/File:Ruzgar-deneme-y%C3%B6netici4.png\" class=\"image\"><img alt=\"Stub icon\" src=\"//upload.wikimedia.org/wikipedia/commons/thumb/f/fb/Ruzgar-deneme-y%C3%B6netici4.png/40px-Ruzgar-deneme-y%C3%B6netici4.png\" width=\"40\" height=\"40\" srcset=\"//upload.wikimedia.org/wikipedia/commons/f/fb/Ruzgar-deneme-y%C3%B6netici4.png 1.5x\" data-file-width=\"48\" data-file-height=\"48\" /></a></td><td><i>This organization-related article is a <a href=\"/wiki/Wikipedia:Stub\" title=\"Wikipedia:Stub\">stub</a>. You can help Wikipedia by <a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Institute_for_Clinical_and_Economic_Review&amp;action=edit\">expanding it</a>.</i><div class=\"plainlinks hlist navbar mini\" style=\"position: absolute; right: 15px; display: none;\"><ul><li class=\"nv-view\"><a href=\"/wiki/Template:Org-stub\" title=\"Template:Org-stub\"><abbr title=\"View this template\">v</abbr></a></li><li class=\"nv-talk\"><a href=\"/wiki/Template_talk:Org-stub\" title=\"Template talk:Org-stub\"><abbr title=\"Discuss this template\">t</abbr></a></li><li class=\"nv-edit\"><a class=\"external text\" href=\"//en.wikipedia.org/w/index.php?title=Template:Org-stub&amp;action=edit\"><abbr title=\"Edit this template\">e</abbr></a></li></ul></div></td></tr></tbody></table>\n\n<!-- \nNewPP limit report\nParsed by mw1272\nCached time: 20180907143743\nCache expiry: 1900800\nDynamic content: false\nCPU time usage: 0.144 seconds\nReal time usage: 0.192 seconds\nPreprocessor visited node count: 364/1000000\nPreprocessor generated node count: 0/1500000\nPost\u2010expand include size: 7886/2097152 bytes\nTemplate argument size: 120/2097152 bytes\nHighest expansion depth: 7/40\nExpensive parser function count: 1/500\nUnstrip recursion depth: 0/20\nUnstrip post\u2010expand size: 7018/5000000 bytes\nNumber of Wikibase entities loaded: 0/400\nLua time usage: 0.058/10.000 seconds\nLua memory usage: 1.97 MB/50 MB\n-->\n<!--\nTransclusion expansion time report (%,ms,calls,template)\n100.00%  150.062      1 -total\n 44.66%   67.012      1 Template:Reflist\n 42.52%   63.803      1 Template:Expand_section\n 28.73%   43.119      1 Template:Cite_journal\n 26.99%   40.497      1 Template:Ambox\n 10.45%   15.683      1 Template:Org-stub\n  9.12%   13.683      1 Template:Asbox\n  2.01%    3.018      1 Template:Main_other\n-->\n\n<!-- Saved in parser cache with key enwiki:pcache:idhash:50351924-0!canonical and timestamp 20180907143743 and revision id 849674682\n -->\n</div>"},"langlinks":[],"categories":[{"sortkey":"","hidden":"","*":"Articles_to_be_expanded_from_April_2016"},{"sortkey":"","hidden":"","*":"All_articles_to_be_expanded"},{"sortkey":"","hidden":"","*":"Articles_using_small_message_boxes"},{"sortkey":"","*":"Organizations_established_in_2005"},{"sortkey":"","*":"Medical_and_health_organizations_based_in_Massachusetts"},{"sortkey":"","*":"Healthcare_management"},{"sortkey":"","hidden":"","*":"All_stub_articles"},{"sortkey":"","*":"Organization_stubs"}],"links":[{"ns":14,"exists":"","*":"Category:Articles to be expanded from April 2016"},{"ns":10,"exists":"","*":"Template:Org-stub"},{"ns":0,"exists":"","*":"AZD-9291"},{"ns":0,"exists":"","*":"Academy of Managed Care Pharmacy"},{"ns":0,"exists":"","*":"Alemtuzumab"},{"ns":0,"exists":"","*":"Brodalumab"},{"ns":0,"exists":"","*":"Daclizumab"},{"ns":0,"exists":"","*":"Dimethyl fumarate"},{"ns":0,"exists":"","*":"Fingolimod"},{"ns":0,"exists":"","*":"Ixekizumab"},{"ns":0,"exists":"","*":"National Institute for Health and Care Excellence"},{"ns":0,"exists":"","*":"Necitumumab"},{"ns":0,"exists":"","*":"Nivolumab"},{"ns":0,"exists":"","*":"PARP inhibitor"},{"ns":0,"exists":"","*":"Pembrolizumab"},{"ns":0,"exists":"","*":"Psoriatic arthritis"},{"ns":0,"exists":"","*":"PubMed Central"},{"ns":0,"exists":"","*":"PubMed Identifier"},{"ns":0,"exists":"","*":"Rociletinib"},{"ns":0,"exists":"","*":"Sovaldi"},{"ns":0,"exists":"","*":"Steven Pearson"},{"ns":0,"exists":"","*":"Teriflunomide"},{"ns":4,"exists":"","*":"Wikipedia:Stub"},{"ns":11,"exists":"","*":"Template talk:Org-stub"}],"templates":[{"ns":10,"exists":"","*":"Template:Expand section"},{"ns":10,"exists":"","*":"Template:Ambox"},{"ns":10,"exists":"","*":"Template:Reflist"},{"ns":10,"exists":"","*":"Template:Cite journal"},{"ns":10,"exists":"","*":"Template:Main other"},{"ns":10,"exists":"","*":"Template:Org-stub"},{"ns":10,"exists":"","*":"Template:Asbox"},{"ns":828,"exists":"","*":"Module:Unsubst"},{"ns":828,"exists":"","*":"Module:Message box"},{"ns":828,"exists":"","*":"Module:No globals"},{"ns":828,"exists":"","*":"Module:Yesno"},{"ns":828,"exists":"","*":"Module:Arguments"},{"ns":828,"exists":"","*":"Module:Message box/configuration"},{"ns":828,"exists":"","*":"Module:Category handler"},{"ns":828,"exists":"","*":"Module:Category handler/data"},{"ns":828,"exists":"","*":"Module:Category handler/config"},{"ns":828,"exists":"","*":"Module:Category handler/shared"},{"ns":828,"exists":"","*":"Module:Category handler/blacklist"},{"ns":828,"exists":"","*":"Module:Namespace detect/data"},{"ns":828,"exists":"","*":"Module:Namespace detect/config"},{"ns":828,"exists":"","*":"Module:Citation/CS1"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Configuration"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Whitelist"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Utilities"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Date validation"},{"ns":828,"exists":"","*":"Module:Citation/CS1/Identifiers"},{"ns":828,"exists":"","*":"Module:Citation/CS1/COinS"},{"ns":828,"exists":"","*":"Module:Check for unknown parameters"},{"ns":828,"exists":"","*":"Module:Asbox"},{"ns":828,"exists":"","*":"Module:Buffer"},{"ns":828,"exists":"","*":"Module:Navbar"}],"images":["Lock-green.svg","Wiki_letter_w_cropped.svg","Ruzgar-deneme-y\u00f6netici4.png"],"externallinks":["//www.ncbi.nlm.nih.gov/pmc/articles/PMC4822973","//www.ncbi.nlm.nih.gov/pubmed/27066190","https://www.statnews.com/pharmalot/2016/04/12/drug-prices-icer/","http://www.ajpb.com/articles/institute-for-clinical-and-economic-review-seeks-to-enhance-healthcare-value","http://www.modernhealthcare.com/article/20150721/NEWS/150729948","http://www.fiercepharma.com/pharma/parp-drugs-from-az-clovis-and-tesaro-are-largely-overpriced-watchdog-says","http://www.fiercepharma.com/pharma/are-new-bone-drugs-from-amgen-and-radius-cost-effective-not-even-close-icer-says","http://icer-review.org/materials/","https://icer-review.org/"],"sections":[{"toclevel":1,"level":"2","line":"Threshold cost criteria","number":"1","index":"1","fromtitle":"Institute_for_Clinical_and_Economic_Review","byteoffset":1802,"anchor":"Threshold_cost_criteria"},{"toclevel":1,"level":"2","line":"Drugs evaluated - reports issued","number":"2","index":"2","fromtitle":"Institute_for_Clinical_and_Economic_Review","byteoffset":2709,"anchor":"Drugs_evaluated_-_reports_issued"},{"toclevel":1,"level":"2","line":"Drug evaluations planned","number":"3","index":"3","fromtitle":"Institute_for_Clinical_and_Economic_Review","byteoffset":3547,"anchor":"Drug_evaluations_planned"},{"toclevel":1,"level":"2","line":"See also","number":"4","index":"4","fromtitle":"Institute_for_Clinical_and_Economic_Review","byteoffset":3962,"anchor":"See_also"},{"toclevel":1,"level":"2","line":"References","number":"5","index":"5","fromtitle":"Institute_for_Clinical_and_Economic_Review","byteoffset":4080,"anchor":"References"},{"toclevel":1,"level":"2","line":"External links","number":"6","index":"6","fromtitle":"Institute_for_Clinical_and_Economic_Review","byteoffset":4108,"anchor":"External_links"}],"parsewarnings":[],"displaytitle":"Institute for Clinical and Economic Review","iwlinks":[],"properties":[{"name":"wikibase_item","*":"Q25104952"}]}}